Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biogazelle Appoints Kris Vanhercke as Chief Operating Officer

Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
New appointment strengthens business development and marketing expertise of Biogazelle.

Biogazelle has announced the appointment of Kris Vanhercke as its new Chief Operating Officer.

Jo Vandesompele and Jan Hellemans, founders and CEO of Biogazelle, stated that this appointment marks a new phase for the company as it has set up a road map for growth. It strengthens its business development and marketing expertise.

Kris brings to Biogazelle an impressive track record from a 20-year career as a leading international executive within the medical device, diagnostics and life sciences industries.

Most recently, Kris was the Sales Director for Roche Diagnostics Belgium, where he was co-responsible for the company’s growth plan in the frame of delivering solutions in the vision of personalized healthcare (diagnostics and pharma).

Before that, he was the business unit manager for novel technologies in the life sciences, molecular diagnostics and tissue diagnostics arena.

He gained international experience when working in international launch teams in Switzerland and Germany and he has 15 years of experience in launching products and services in the clinical biology market.

He gained also experience as COO in the Gulf region (Middle East).

Kris started his career with a scientific-sales position at Boehringer Mannheim and gradually learned how to turn scientific ideas in to solid marketing concepts, developing business out of high-technology products in specific niche markets.

“Therefore, Kris is a great asset for Biogazelle in realizing its ambitious growth plans by exploiting his insights gained in a multi-national environment. Kris will help us to offer our products and services on a global level.” stated one of the founders Jo Vandesompele.

Commenting on his new role, Kris said: “Considering the dynamism of the team, the yes-we-can-attitude, together with the high-level scientific products and services offered today and in the pipeline, I believe that this company has the potential to grow as THE qPCR company. Moreover, Biogazelle has the potential to grow from a course and software provider to a service provider, offering complete solutions in gene expression, and microRNA and long non-coding RNA profiling.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biogazelle Attracts New Investors
UGent spin-off Biogazelle attracts new investors QBIC Arkiv Fund, Foundation Majoie and SOFI to finance growth.
Tuesday, October 07, 2014
Biogazelle Serves as Reference Laboratory for Bio-Rad's ddPCR System
Biogazelle’s and Bio-Rad’s long-term partnership extends.
Monday, September 30, 2013
VIB Inks qBase+ Group Licensing Agreement with Biogazelle
VIB to accelerate its qPCR analyses by using qbase+ as the software.
Monday, May 20, 2013
Scientific News
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Using Cancer Cells' Mass to Predict Treatment Response
A device has been developed that can detect changes in cell mass at a minute scale.
NVIDIA Awards $400k to Trailblazers in Cancer Research
NVIDIA Foundation furthers research that could lead to new and more targeted treatments with investments.
Malaria Parasite Evades Rapid Test Detection in Children
A study at the University of North Carolina found that gene deletion poses a threat to Malaria eradication efforts.
Working With Advanced Nanoimagers
Oxford Nanoimaging report on the work of early-adopters for their Nanoimager technology at the MRC Centre for Molecular Bacteriology and Infection.
History of Cells Told Through MEMOIR
MEMOIR technique developed by CalTech researchers enables the life history of cells to be read.
Nanoscale ‘Muscles’ Powered by DNA
Scientists have developed nanoscale "muscles" to integrate with custom DNA, that can force the material to bend, curl and flip.
Dissecting Bacterial Infections at the Single-Cell Level
Researchers have used single-cell analysis technology to provide new insight into the Salmonella infection process.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Cancer Stem Cells Fuel Tumor Growth
Mass. General, Broad Institute team finds strong evidence that cancer stem cells are important drivers of tumors in patients.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!